# Regenxbio

**Source:** https://www.startuphub.ai/startups/regenxbio
**Profile type:** Startup

> Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

## About

REGENXBIO is a clinical-stage biotechnology company focused on developing gene therapies using its proprietary NAV Technology Platform, which utilizes adeno-associated virus (AAV) vectors. The company aims to improve lives by delivering one-time treatments for rare and retinal diseases, as well as metabolic and neurodegenerative conditions. Their pipeline includes investigational therapies for Duchenne muscular dystrophy, MPS II, MPS I, and wet age-related macular degeneration.

## Key facts

- **Slug:** regenxbio
- **Website:** https://www.regenxbio.com/
- **Location:** Rockville, United States
- **Founded:** 2008-01-01
- **Employees:** 396
- **Operating status:** Active
- **Total funding:** $180M
- **Sectors / tags:** Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Gene Therapy, AAV Vectors
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/regenx
  - Twitter: https://twitter.com/REGENXBIO

## Frequently asked

### What does Regenxbio do?

REGENXBIO is a clinical-stage biotechnology company focused on developing gene therapies using its proprietary NAV Technology Platform, which utilizes adeno-associated virus (AAV) vectors. The company aims to improve lives by delivering one-time treatments for rare and retinal diseases, as well as metabolic and neurodegenerative conditions. Their pipeline includes investigational therapies for Duchenne muscular dystrophy, MPS II, MPS I, and wet age-related macular degeneration.

### What is Regenxbio's revenue?

StartupHub estimates Regenxbio's annual revenue at $93.8M (range $50.8M to $161.5M, 64% confidence), based on comparable companies in the sector.

### What is Regenxbio's valuation?

StartupHub estimates Regenxbio's effective valuation at $738.0M (range $450.0M to $1.1B, 18% confidence), based on comparable companies in the sector.

### How much funding has Regenxbio raised?

Regenxbio has raised a total of $180M in funding. The most recent round on record is Funding Round.

### Where is Regenxbio headquartered?

Regenxbio is headquartered in Rockville, United States.

### When was Regenxbio founded?

Regenxbio was founded in 2008.

### What industry does Regenxbio operate in?

Regenxbio operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Gene Therapy.

### How many employees does Regenxbio have?

Regenxbio has approximately 396 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Regenxbio",
          "item": "https://www.startuphub.ai/startups/regenxbio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/regenxbio#webpage",
      "url": "https://www.startuphub.ai/startups/regenxbio",
      "name": "Regenxbio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Regenxbio. Regenxbio is a startup founded in 2008, operating in Biotech and MedTech. Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. Headquartered in Rockville, United States. The company has approximately 396 employees.",
      "dateModified": "2026-05-06T06:00:00.173+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/regenxbio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/regenxbio#organization",
      "name": "Regenxbio",
      "url": "https://www.regenxbio.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/a0be8453-795e-4258-b65a-387f0edda420-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/a0be8453-795e-4258-b65a-387f0edda420-square.webp",
      "description": "This is the official profile of Regenxbio. Regenxbio is a startup founded in 2008, operating in Biotech and MedTech. Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. Headquartered in Rockville, United States. The company has approximately 396 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/regenx",
        "https://twitter.com/REGENXBIO",
        "https://www.startuphub.ai/startups/regenxbio"
      ],
      "foundingDate": "2008-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 396
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Rockville",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotech",
        "MedTech",
        "HealthTech",
        "Drug Discovery",
        "Clinical Trials",
        "Gene Therapy",
        "AAV Vectors"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/regenxbio#profile-assessment",
      "name": "Regenxbio - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/regenxbio",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/a0be8453-795e-4258-b65a-387f0edda420-square.webp",
      "category": "Biotech",
      "description": "This is the official profile of Regenxbio. Regenxbio is a startup founded in 2008, operating in Biotech and MedTech. Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. Headquartered in Rockville, United States. The company has approximately 396 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/regenxbio/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Regenxbio"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-06",
        "name": "Regenxbio - Profile Score 55/100",
        "reviewBody": "This is the official profile of Regenxbio. Regenxbio is a startup founded in 2008, operating in Biotech and MedTech. Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. Headquartered in Rockville, United States. The company has approximately 396 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/regenxbio/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 55,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```